Biopharma News
Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines
A loan from the Province of Nova Scotia will support Immunovaccine's clinical studies through 2016.
iQur Leads Major European Project to Develop a Universal Influenza Virus Vaccine
iQur announced that it has been granted 5 million EUR ($6.6 million) by the European Union Framework 7 fund to develop a universal influenza vaccine.
Immunocore Signs Research and Licensing Agreement with GSK
Immunocore Limited has entered into a partnership with GlaxoSmithKline for multiple novel targets not addressable using antibody-based technologies.
Aspen to Acquire Select API Assets and Finished Products from Merck
The $1-billion deal includes select parts of Merck?s manufacturing site in Oss, The Netherlands and Sioux City, Iowa as well as 11 finished products.
MorphoSys and Celgene Sign Monoclonal Antibody Pact
The companies agree to jointly develop and promote MOR202, an oncology mAb in a deal potentially valued at more than $800 million.
FDA Discovers Microbial Contamination in Compound Pharmacy Products
Novartis Receives FDA Warning Letter for cGMP Violations at Austrian Plant
The company is cited for using unapproved visual-inspection methods for finished parenteral drugs and conducting inadequate visual inspections.
Celerion Adds Containment Room
Modular containment room at Belfast facility allows studies of biologics and vaccines.
MorphoSys and GlaxoSmithKline Partner in Antibody Pact
-
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
Program aims to develop a novel oral treatment.
